News and Features
Updated HHS Perinatal Antiretroviral Treatment Guidelines Released
The HHS Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission announces the release of the updated Recommendations for the Use of Antiretroviral Drugs in Pregnant Women with HIV Infection and Interventions to Reduce Perinatal HIV Transmission in the United States.
For a complete preview of key updates to the guidelines, please see What's New in the Guidelines. Additions and revisions are also highlighted in yellow throughout the PDF version of the guidelines.
To view or download the guidelines, go to the Perinatal Guidelines section of AIDSinfo. Separate PDF files of the tables or recommendations can also be downloaded from the page.
Your Feedback Is Welcome
Feedback on the latest revisions to the Recommendations for the Use of Antiretroviral Drugs in Pregnant Women with HIV Infection and Interventions to Reduce Perinatal HIV Transmission in the United States is welcome. Please send your comments with the subject line “Comments on the Perinatal Guidelines” to ContactUs@aidsinfo.nih.gov by November 29, 2017.
Updates to the Pediatric Antiretroviral Guidelines
A new section, Antiretroviral Management of Newborns with Perinatal HIV Exposure or Perinatal HIV, has been added to the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. Maternal HIV Testing and Identification of Perinatal HIV Exposure and Diagnosis of HIV Infection in Infants and Children were also updated. These sections were developed in collaboration with the Perinatal Guidelines panel. For more information, see What's New in the Guidelines.